Vnitr Lek 2012, 58(6):427-429

Strategie dávkování antibiotik u kriticky nemocných s potřebou náhrady funkce ledvin - maximální účinnost při minimální toxicitě! - editorial

J. Raděj, M. Matějovič*
I. interní klinika Lékařské fakulty UK a FN Plzeň, přednosta prof. MUDr. Martin Matějovič, Ph.D.

Received: February 27, 2012; Published: June 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Raděj J, Matějovič M. Strategie dávkování antibiotik u kriticky nemocných s potřebou náhrady funkce ledvin - maximální účinnost při minimální toxicitě! - editorial. Vnitr Lek. 2012;58(6):427-429.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Matejovic M, Chvojka J, Radej J et al. Sepsis and acute kidney injury are bidirectional. Contrib Nephrol 2011; 174: 78-88. Go to original source... Go to PubMed...
    2. Petejova N, Martínek A, Zahálková J et al. Vliv kontinuální a intermitentní náhrady renálních funkcí na antibiotickou léčbu u kriticky nemocných v sepsi - praktický pohled na léčbu vankomycinem a gentamicinem. Vnitř Lék 2012; 58(6): 448-454. Go to PubMed...
    3. Matějovič M. Desatero akutního selhání ledvin. Postgraduální medicína 2011; 13: příloha č. 3.
    4. Seyler L, Cotton F, Taccone FS et al. Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy. Crit Care 2011; 15: R137. Go to original source... Go to PubMed...
    5. Radej J, Krouzecky A, Stehlik P et al. Pharmacokinetic evaluation of voriconazole treatment in critically ill patients undergoing continuous venovenous hemofiltration. Ther Drug Monit 2011; 33: 393-397. Go to original source... Go to PubMed...
    6. Gálvez R, Luengo C, Cornejo R et al. Higher than recommended amikacin loading doses achieve pharmacokinetic targets without associated toxicity. Int J Antimicrob Agents 2011; 38: 146-151. Go to original source... Go to PubMed...
    7. Michalopoulos AS, Falagas ME. Colistin: recent data on pharmacodynamics properties and clinical efficacy in critically ill patients. Ann Intensive Care 2011; 1: 30. Go to original source... Go to PubMed...
    8. Bouman CS. Antimicrobial dosing strategies in critically ill patients with acute kidney injury and high-dose continuous veno-venous hemofiltration. Curr Opin Crit Care 2008; 14: 654-659. Go to original source... Go to PubMed...
    9. Choi G, Gomersall CD, Tian Q et al. Principles of antibacterial dosing in continuous renal replacement therapy. Blood Purif 2010; 30: 195-212. Go to original source... Go to PubMed...
    10. Dostál P. Dávkování farmak a kontinuální eliminační metody. In: Novák I, Matějovič M, Černý V et al (eds). Akutní selhání ledvin a eliminační techniky v intenzívní péči. Praha: Maxdorf 2008.
    11. Gilbert DN, Moellering Jr RC, Eliopoulos GM et al (eds). The Sanford Guide to Antimicrobial Therapy. Sperryville, USA: Antimicrobial Therapy, Inc 2011.
    12. Choi G, Gomersall CD, Tian Q et al. Principles of antibacterial dosing in continuous renal replacement therapy. Crit Care Med 2009; 37: 2268-2282 Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.